SPARK is honored to receive the 2020 Janet Davison Rowley Patient Impact Research Award!
Congratulations to Dr. Kevin Grimes, who has joined The Kenneth Rainin Foundation as a Scientific Advisory Board member!
“I look forward to providing input that may help the Foundation’s outstanding group of researchers progress their discoveries.”
– Dr. Kevin Grimes
In developing new drugs for rare diseases, this non-profit steps in when pharmaceutical companies won’t
A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain cancer drug, one that might have ended up overlooked by pharmaceutical companies.Read More »
Congratulations to Dr. Kevin Grimes who has been officially promoted to Professor in the NTL-Teaching line.Read More »
SPARK was designed to bridge the gap between academia and industry. Founded by Daria Mochly-Rosen, PhD, and co-directed by Kevin Grimes, MD, the program transports research from the lab to patients by guiding and supporting researchers, with the help of industry advisors.Read More »
Read the latest review on the SPARK founders, CSB professors Daria Mochly-Rosen and Kevin Grimes’s publication A Practical Guide to Drug Development in Academia: the SPARK Approach in the current edition of Nature Chemical Biology: Translational research: Drug Discovery from the Inside by Derek Lowe.Read More »
The SPARK team, including professors Daria Mochly-Rosen and Kevin Grimes, are happy to announce A Practical Guide to Drug Development in Academia: the SPARK Approach was recently published through SpringerBriefs. The book serves as a general introduction to academics new to drug discovery or translational research.Read More »